IN THE NEWS....
VUB team develops nanobody technology against liver inflammation
VUB Today | 4 December 2023
Mathieu Vinken, a professor in the In Vitro Toxicology and Dermato-cosmetology lab at the Vrije Universiteit Brussel, and doctoral student Raf Van Campenhout have developed a technique based on nanobody technology to prevent liver inflammation. Nanobodies, or single-domain antibodies, are fragments of antibodies that can selectively bind to a specific antigen. Because they are simple to produce and react in very specific ways, they are often used in various biotechnological, therapeutic and diagnostic applications.
Data science: empowering animal-free progress in preclinical development
BioVox | 25 April 2023
Many drugs fail clinical trials, often because preclinical animal models fall short of replicating human physiology. To improve animal welfare, speed up drug development, and reduce costs, we need to rely less on animal models, while also minimizing the number of failures early in the drug development process. Artificial intelligence and machine learning are powerful tools that can help us achieve these goals by predicting a drug’s efficacy, safety, and uptake in preclinical studies. These technologies can help researchers to make informed decisions and optimize testing strategies, improving drug development for both animals and people.
How non-animal testing can reshape health and environment policies
Voxeurope | 23 April 2021
Footage capturing unacceptable cruelty and abuse on animals in a Spanish testing facility has recently made headlines and prompted many reactions. The 24th of April is celebrated as the World Day of Animals in Laboratories. Its objective is to promote alternatives to animal testing that are currently revolutionising toxicology, a domain of research where the European Union has significantly increased funding to advance chemical safety assessment.
Vlaamse prof wil proefdieren redden: computer moet plaats innemen van deze muisjes
Het Laatste Nieuws | 06 February 2021
Nemen computers binnen enkele jaren de 'lijdende' plek van veel proefdieren in? Binnenkort start een internationaal team onder leiding van de Vlaamse toxicoloog Mathieu Vinken (VUB) met de ontwikkeling van zo'n 'proefcomputer'. "Daarmee kunnen op de lange termijn behoorlijk wat proefdieren gespaard worden", hoopt professor Vinken.